MCA stability tool

Check whether tablets and capsules are suitable for a multi-compartment compliance aid (MCA), and build a list to print.

Browse medicines A to Z

Medicines beginning with S

Selexipag

Selexipag 1.2mg tablets

No stability information

Stability notes for Selexipag 1.2mg tablets

There are no stability notes for this medicine.

Supplier

Uptravi 1,200microgram tablets (Janssen-Cilag Ltd)

Selexipag 1.4mg tablets

No stability information

Stability notes for Selexipag 1.4mg tablets

There are no stability notes for this medicine.

Supplier

Uptravi 1,400microgram tablets (Janssen-Cilag Ltd)

Selexipag 1.6mg tablets

No stability information

Stability notes for Selexipag 1.6mg tablets

There are no stability notes for this medicine.

Supplier

Uptravi 1,600microgram tablets (Janssen-Cilag Ltd)

Selexipag 1mg tablets

No stability information

Stability notes for Selexipag 1mg tablets

There are no stability notes for this medicine.

Supplier

Uptravi 1,000microgram tablets (Janssen-Cilag Ltd)

Selexipag 200microgram tablets

No stability information

Stability notes for Selexipag 200microgram tablets

There are no stability notes for this medicine.

Supplier

Uptravi 200microgram tablets (Janssen-Cilag Ltd)

Selexipag 400microgram tablets

No stability information

Stability notes for Selexipag 400microgram tablets

There are no stability notes for this medicine.

Supplier

Uptravi 400microgram tablets (Janssen-Cilag Ltd)

Selexipag 600microgram tablets

No stability information

Stability notes for Selexipag 600microgram tablets

There are no stability notes for this medicine.

Supplier

Uptravi 600microgram tablets (Janssen-Cilag Ltd)

Selexipag 800microgram tablets

No stability information

Stability notes for Selexipag 800microgram tablets

There are no stability notes for this medicine.

Supplier

Uptravi 800microgram tablets (Janssen-Cilag Ltd)

What the ratings mean

Compatible
Suitable for use. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label.
Use with caution
Suitable with mitigations. Keep in MCA for shortest possible time: no more than 5 weeks for non-airtight; 8 weeks for airtight. Use likely to be off-label and supported by limited data.
Incompatible
Medicines under this category are not suitable for use in MCAs.
No stability information
These medicines have not been reviewed by SPS.